Imipenem cilastatin contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{imipenem cilastatin}} | {{imipenem cilastatin}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==Contraindications== | ==Contraindications== |
Revision as of 22:32, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
PRIMAXIN I.V. is contraindicated in patients who have shown hypersensitivity to any component of this product.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf" (PDF). External link in
|title=
(help)
Adapted from the FDA Package Insert.